Scholarly Index
Rutie Yin
Sichuan University; 2,537 total citations; 194 total publications; best world rank #47
Sichuan University
2,537Total citations
194Total publications
23H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| PARP inhibition in cancer therapy | Lifetime | 991 | CN 47 | 90.71 |
| Gestational Trophoblastic Disease Studies | Lifetime | 510 | CN 26 | 86.96 |
| Ovarian cancer diagnosis and treatment | 2021-2025 | 91 | CN 2 | 98.34 |
| PARP inhibition in cancer therapy | 2021-2025 | 93 | CN 2 | 96.58 |
| Endometrial and Cervical Cancer Treatments | 2021-2025 | 462 | CN 30 | 93.25 |
| Cervical Cancer and HPV Research | 2021-2025 | 513 | CN 51 | 91.30 |
| BRCA gene mutations in cancer | 2021-2025 | 483 | CN 7 | 88.65 |
| Gestational Trophoblastic Disease Studies | 2021-2025 | 47 | CN 8 | 86.95 |
| Genital Health and Disease | 2021-2025 | 832 | CN 63 | 72.39 |
| Ectopic Pregnancy Diagnosis and Management | 2021-2025 | 607 | CN 80 | 66.48 |
| Toxin Mechanisms and Immunotoxins | 2021-2025 | 786 | CN 133 | 59.50 |
| PI3K/AKT/mTOR signaling in cancer | 2021-2025 | 970 | CN 219 | 59.46 |